New Key Statistics Module, Z-Score and F-Score
OTCPK:SPHDF Key Ratios
| Market Cap $ M | 296.97 |
| Enterprise Value $ M | 329.53 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 209.46 |
| Price/Book | -- |
| Price/Sales | 2.69 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 96.00 |
| EPS (TTM) $ | -4.67 |
| Beneish M-Score | -1.06 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.16 |
| EV-to-EBITDA | -8.43 |
| PEG | -- |
| Shares Outstanding M | 15.25 |
| Net Margin (%) | -63.79 |
| Operating Margin % | -48.73 |
| Pre-tax Margin (%) | -63.55 |
| Quick Ratio | 0.89 |
| Current Ratio | 1.29 |
| ROA % (ttm) | -34.24 |
| ROE % (ttm) | -1,109.00 |
| ROIC % (ttm) | -34.61 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.54 |
SPHDF Number of Guru Trades
SPHDF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SPHDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SPHDF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Santhera Pharmaceuticals Holding AG Insider Transactions
No Available Data
News about OTCPK:SPHDF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers